Romanian-Swiss Research Programme IZERZO
NCT03237884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 308
Last updated 2017-08-03
Summary
Palliative Care procedures should be integrated early in the course of disease of patients with advanced incurable cancer. With this study, where the investigators follow adult patients with incurable cancer over 6 months or until death (whatever occurs earlier), the investigators aim to identify patients' needs for Palliative Care interventions (like support in illness understanding and decision making, symptom management, concrete end-of-life preparation, and others) and their remembered delivery by health care professionals. The investigators also collect data on patients care (use of chemotherapy, intensive care in the last month of life) and quality of death and dying (assessed by post-death-interviews with bereaved relatives). The aim is to have a "reality map" on current integration of oncology and palliative care and to test if appropriate Palliative Care interventions predict a better outcome.
Conditions
- Advanced Incurable Cancer
Sponsors & Collaborators
-
Cantonal Hospital of St. Gallen
lead OTHER
Principal Investigators
-
Florian Strasser, MD · Cantonal Hospital of St. Gallen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-01
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Romania
- Switzerland
Study Locations
More Related Trials
-
Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma
NCT00072124 ·Status: COMPLETED ·Phase: PHASE3
-
Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma
NCT06712459 ·Status: RECRUITING
-
Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles
NCT00658294 ·Status: COMPLETED
-
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
NCT01666418 ·Status: COMPLETED ·Phase: PHASE2
-
pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE
NCT05171374 ·Status: UNKNOWN
-
Burden and Medical Care of Sarcoma in Germany
NCT03521531 ·Status: COMPLETED
-
Suicide Plus Immune Gene Therapy for Advanced Melanoma
NCT03338777 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
NCT01409174 ·Status: TERMINATED ·Phase: PHASE1
-
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
NCT00226473 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients
NCT00936221 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma
NCT01672450 ·Status: COMPLETED ·Phase: PHASE1
-
Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.
NCT03972748 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France
NCT04550247 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection
NCT03980314 ·Status: COMPLETED ·Phase: PHASE1
-
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
NCT02186249 ·Status: NO_LONGER_AVAILABLE
-
This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)
NCT06805669 ·Status: RECRUITING ·Phase: NA
-
The Jules Bordet Institute Molecular Profiling Program Feasibility Trial
NCT01932489 ·Status: COMPLETED ·Phase: NA
-
Long Term Quality of Life in Melanoma Patients in Netherlands
NCT03450876 ·Status: COMPLETED
-
Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients
NCT06207747 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
NCT05229614 ·Status: RECRUITING ·Phase: PHASE2
-
Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma
NCT05783882 ·Status: UNKNOWN ·Phase: PHASE3
-
Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
NCT01496807 ·Status: COMPLETED ·Phase: PHASE1
-
Melanoma Detection in Switzerland With VECTRA
NCT04605822 ·Status: COMPLETED
-
Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma
NCT02507076 ·Status: WITHDRAWN ·Phase: NA
-
Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy
NCT04652258 ·Status: TERMINATED ·Phase: PHASE2